Abstract
Following failed endoscopic intervention, the most cost-effective strategy for recurrent urethral stricture disease (USD) is urethroplasty. Inpatient hospital costs associated with urethroplasty are driven by patient comorbidities and postoperative complications. Symptom-based surveillance for USD recurrence will reduce unnecessary diagnostic procedures and cost.
Original language | English |
---|---|
Pages (from-to) | 11-17 |
Number of pages | 7 |
Journal | Urologic Clinics of North America |
Volume | 44 |
Issue number | 1 |
DOIs | |
State | Published - Feb 1 2017 |
Keywords
- Cost-effectiveness
- Urethroplasty
- Utilization